Uploaded August 2026 | Updated September 2026, 2 weeks ago
Some endometriosis patients say GLP-1 medications are helping improve their symptoms, but research into the potential connection remains limited and the drugs are not FDA-approved to treat endometriosis.
Savannah Regensburger, an endometriosis patient and clinical research manager, says tirzepatide, better known by the brand names Zepbound and Mounjaro, has helped reduce symptoms including bloating, brain fog and flares. She is now working with Dr. Chandra Spring-Robinson to study the connection between GLP-1s and endometriosis.
Researchers in Connecticut are also investigating. UConn Health and The Jackson Laboratory are studying tissue collected from endometriosis patients taking GLP-1s. Dr. Danielle Luciano, UConn Health OB/GYN chair and co-director of the Connecticut EndoRISE program, says researchers are seeing signals they hope to better understand, while stressing that GLP-1s may not work for everyone.
Dr. Spring-Robinson advises patients against obtaining GLP-1 medications from a medical spa or online and encourages women to first speak with an endometriosis specialist.
Visit nbcconnecticut.com for the latest in news, weather, entertainment, sports and other great content.
NBC CT Facebook facebook.com/NBCConnecticut
NBC CT Instagram instagram.com/nbcconnecticut
#nbc #nbcconnecticut #ConnectingYou #nbcct
Download the NBC Connecticut app: nbcconnecticut.app.link/NuGsXNFUWGb
Some endometriosis patients say GLP-1 medications are helping improve their symptoms, but research into the potential connection remains limited and the drugs are not FDA-approved to treat endometriosis.
Savannah Regensburger, an endometriosis patient and clinical research manager, says tirzepatide, better known by the brand names Zepbound and Mounjaro, has helped reduce symptoms including bloating, brain fog and flares. She is now working with Dr. Chandra Spring-Robinson to study the connection between GLP-1s and endometriosis.
Researchers in Connecticut are also investigating. UConn Health and The Jackson Laboratory are studying tissue collected from endometriosis patients taking GLP-1s. Dr. Danielle Luciano, UConn Health OB/GYN chair and co-director of the Connecticut EndoRISE program, says researchers are seeing signals they hope to better understand, while stressing that GLP-1s may not work for everyone.
Dr. Spring-Robinson advises patients against obtaining GLP-1 medications from a medical spa or online and encourages women to first speak with an endometriosis specialist.
Visit nbcconnecticut.com for the latest in news, weather, entertainment, sports and other great content.
NBC CT Facebook facebook.com/NBCConnecticut
NBC CT Instagram instagram.com/nbcconnecticut
#nbc #nbcconnecticut #ConnectingYou #nbcct
Download the NBC Connecticut app: nbcconnecticut.app.link/NuGsXNFUWGb
